Table 1 Clinico-pathologic and molecular features of gliomas, MPNST, and neurofibromas
From: Telomere alterations in neurofibromatosis type 1-associated solid tumors
Gliomas | MPNST | Neurofibromas | |
|---|---|---|---|
(N = 70) | (N = 152) | (N = 77)a | |
Mean age (SD) | 20.6 (13.8) | 38.9 (17.3) | 30.6 (17.7) |
Gender (%) | |||
Male | 52.9 | 49.0 | 48.1 |
Female | 47.1 | 51.0 | 52.0 |
Grade (%) | |||
High | 32.9 | 88.7 | – |
Low | 67.1 | 11.3 | – |
ALT status (%) | |||
Positive | 32.9 | 16.6 | – |
Negative | 67.1 | 81.5 | – |
Missing | – | 2.0 | – |
Telomeres (%) | |||
Normal | 24.3 | 9.9 | – |
Short | 1.4 | 9.3 | – |
Long | 17.1 | 0.7 | – |
ALT | 32.9 | 16.6 | – |
Missing | 24.3 | 63.6 | – |
NF status (%) | |||
NF1 | – | 61.6 | – |
Unknown | – | 38.4 | – |